Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 159

Related Citations for PubMed (Select 11075857)

1.

Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression.

Iacobuzio-Donahue CA, Wilentz RE, Argani P, Yeo CJ, Cameron JL, Kern SE, Hruban RH.

Am J Surg Pathol. 2000 Nov;24(11):1544-8.

PMID:
11075857
2.

Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.

Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, Wilentz RE, Argani P, Sohn TA, Yeo CJ, Cameron JL, Kern SE, Hruban RH.

Am J Pathol. 2000 Sep;157(3):755-61.

3.

Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.

Biankin AV, Biankin SA, Kench JG, Morey AL, Lee CS, Head DR, Eckstein RP, Hugh TB, Henshall SM, Sutherland RL.

Gut. 2002 Jun;50(6):861-8.

4.

Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.

Sasaki S, Yamamoto H, Kaneto H, Ozeki I, Adachi Y, Takagi H, Matsumoto T, Itoh H, Nagakawa T, Miyakawa H, Muraoka S, Fujinaga A, Suga T, Satoh M, Itoh F, Endo T, Imai K.

Oncol Rep. 2003 Jan-Feb;10(1):21-5.

PMID:
12469138
5.

Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling.

McCarthy DM, Brat DJ, Wilentz RE, Yeo CJ, Cameron JL, Kern SE, Hruban RH.

Hum Pathol. 2001 Jun;32(6):638-42.

PMID:
11431719
6.

Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.

Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, Kern SE, Hruban RH.

Cancer Res. 2000 Apr 1;60(7):2002-6.

7.

Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases.

McCarthy DM, Hruban RH, Argani P, Howe JR, Conlon KC, Brennan MF, Zahurak M, Wilentz RE, Cameron JL, Yeo CJ, Kern SE, Klimstra DS.

Mod Pathol. 2003 Mar;16(3):272-8.

8.

The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas.

Lüttges J, Feyerabend B, Buchelt T, Pacena M, Klöppel G.

Am J Surg Pathol. 2002 Apr;26(4):466-71.

PMID:
11914624
10.

Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct.

Tascilar M, Offerhaus GJ, Altink R, Argani P, Sohn TA, Yeo CJ, Cameron JL, Goggins M, Hruban RH, Wilentz RE.

Am J Clin Pathol. 2001 Dec;116(6):831-7.

11.

MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).

Ueda M, Miura Y, Kunihiro O, Ishikawa T, Ichikawa Y, Endo I, Sekido H, Togo S, Shimada H.

Hepatogastroenterology. 2005 Mar-Apr;52(62):398-403.

PMID:
15816444
12.

Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.

Maitra A, Molberg K, Albores-Saavedra J, Lindberg G.

Am J Pathol. 2000 Oct;157(4):1105-11.

13.

Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

Wilentz RE, Su GH, Dai JL, Sparks AB, Argani P, Sohn TA, Yeo CJ, Kern SE, Hruban RH.

Am J Pathol. 2000 Jan;156(1):37-43.

14.

Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.

Hua Z, Zhang YC, Hu XM, Jia ZG.

World J Gastroenterol. 2003 Dec;9(12):2764-7.

15.

Periostin deposition in the stroma of invasive and intraductal neoplasms of the pancreas.

Fukushima N, Kikuchi Y, Nishiyama T, Kudo A, Fukayama M.

Mod Pathol. 2008 Aug;21(8):1044-53. doi: 10.1038/modpathol.2008.77. Epub 2008 May 16.

16.

[Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].

Gu LJ, Chen J, Liu TH, Cui QC, Lu ZH, Li L, Gao J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002 Apr;24(2):165-9. Chinese.

PMID:
12905795
17.

Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.

Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD, Sarkar FH, Hruban RH, Klimstra DS.

Am J Surg Pathol. 2004 Jul;28(7):839-48.

PMID:
15223952
19.

Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.

Furukawa T, Fujisaki R, Yoshida Y, Kanai N, Sunamura M, Abe T, Takeda K, Matsuno S, Horii A.

Mod Pathol. 2005 Aug;18(8):1034-42.

20.

The relationship between loss expression of DPC4/Smad4 gene and carcinogenesis of pancreatobiliary carcinoma.

Tang ZH, Zou SQ, Hao YH, Wang BJ, Yang XP, Chen QQ, Qiu FZ.

Hepatobiliary Pancreat Dis Int. 2002 Nov;1(4):624-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk